Related Experiment Video
Updated: May 26, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
What are we looking for in new antipsychotics?
1The Zucker Hillside Hospital, Psychiatry Research, 75-59 263rd St, Glen Oaks, NY 11004, USA. ccorrell@lij.edu
The Journal of Clinical Psychiatry
|January 6, 2012
Summary
Future antipsychotics should offer balanced efficacy and safety for treating psychotic disorders. Enhanced agents aim for better outcomes in negative symptoms, cognitive function, and patient well-being, improving recovery.
Area of Science:
- Psychopharmacology
- Neuroscience
- Clinical Psychiatry
Background:
- Antipsychotics are essential for treating psychotic and some nonpsychotic disorders.
- Despite advances, significant unmet needs persist in current antipsychotic therapy.
- Developing novel antipsychotics with improved profiles remains a critical challenge.
Purpose of the Study:
- To review desirable properties for next-generation antipsychotics.
- To evaluate how current antipsychotic agents measure up against these ideal characteristics.
- To identify key areas for future research and development in antipsychotic medications.
Main Methods:
- Literature review of desirable pharmacodynamic and pharmacokinetic properties.
- Comparative analysis of current antipsychotics against ideal profiles.
- Discussion of challenges in antipsychotic drug development and clinical trials.
Main Results:
- Ideal future antipsychotics require a balanced pharmacodynamic profile for efficacy without compromising well-being.
- Desired pharmacokinetic profiles include safety, speed, convenience, and multiple formulations.
- New agents should match or exceed current efficacy for positive symptoms while improving on negative/cognitive symptoms, relapse prevention, and treatment resistance.
Conclusions:
- Future antipsychotics must improve tolerability, patient adherence, functioning, and quality of life for better recovery.
- Greater insight into schizophrenia pathophysiology is needed for novel mechanisms and true breakthroughs.
- Drug-specific biomarkers are crucial for personalized psychiatric care and improved patient outcomes.
Related Concept Videos
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...